TRNP-1 Inhibitors
TRNP-1 Inhibitors are a diverse set of chemical compounds that indirectly lead to the diminishment of TRNP-1 function by targeting various cellular signaling pathways and processes. Compounds such as Staurosporine and SP600125 exert their effects by inhibiting general protein kinases and JNK, respectively, which play crucial roles in downstream signaling that may be necessary for TRNP-1's role in chromatin remodeling and cell growth. Rapamycin, LY 294002, and Wortmannin are all inhibitors of the mTOR and PI3K/AKT pathways, which are critical for cell proliferation and survival; their inhibition likely leads to reduced activity of TRNP-1 in these processes. Additionally, Cyclopamine's targeting of the Hedgehog pathway and DAPT's inhibition of gamma-secretase and subsequent Notch signaling are examples of how TRNP-1 function can be indirectly reduced due to the compound's influence on pathways involved in cell proliferation and differentiation where TRNP-1 is active.
The MAPK pathway, another pivotal cell regulatory mechanism, can be influenced by compounds like U0126, PD 98059, and SB 203580, which are inhibitors of MEK and p38 MAPK. These inhibitors indirectly lead to decreased TRNP-1 activity by affecting the pathway's role in cell cycle regulation. Furthermore, Bafilomycin A1 and Thapsigargin disrupt intracellular processes such as endosomal-lysosomal acidification and calcium homeostasis, respectively, which could have downstream effects on TRNP-1's involvement in cellular turnover and signaling. Collectively, these TRNP-1 inhibitors, through their targeted disruption of key signaling pathways and cellular processes, result in the diminished functional activityof TRNP-1 without directly affecting its transcription or translation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent non-selective protein kinase inhibitor that indirectly inhibits TRNP-1 by blocking the phosphorylation of downstream targets that may be required for TRNP-1 chromatin remodeling activities. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that indirectly diminishes TRNP-1 function by inhibiting the mTOR pathway, which is involved in cell growth and proliferation, processes where TRNP-1 is implicated. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
A Hedgehog signaling pathway inhibitor that could decrease TRNP-1 activity by inhibiting the pathway's downstream effects on cell proliferation, where TRNP-1 plays a role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can lead to reduced TRNP-1 activity by inhibiting the PI3K/AKT pathway, which is linked to cell cycle progression and growth, processes that involve TRNP-1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An MEK inhibitor that indirectly diminishes TRNP-1 activity by inhibiting the MAPK/ERK pathway, which is associated with cell cycle regulation wherein TRNP-1 could be involved. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor that can decrease TRNP-1 function by blocking the MAPK/ERK signaling involved in cellular proliferation and differentiation, where TRNP-1 is implicated. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that may indirectly reduce TRNP-1 activity by inhibiting p38 MAPK signaling, affecting processes like cell stress response and development that involve TRNP-1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK that can decrease TRNP-1 function by inhibiting JNK signaling, which participates in cell growth and apoptosis, processes that may involve TRNP-1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can indirectly decrease TRNP-1 activity by blocking the PI3K/AKT pathway, which is important for cell growth and survival where TRNP-1 is involved. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
A V-ATPase inhibitor that can diminish TRNP-1 function by disrupting endosomal-lysosomal acidification, potentially affecting the cellular turnover processes that involve TRNP-1. | ||||||